TITLE

Clinical pharmacology

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS12
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Differences in substrate affinities for CYP3A isoforms using a recombinant vaccinia expression system,' by R.B. Kim, C. Wandel et al from the Vanderbilt University. Cytochrome P450 (CYP).
ACCESSION #
9708235792

 

Related Articles

  • Cytochrome P450 proteins and potential utilization in biodegradation. Guengerich, F. Peter // Environmental Health Perspectives Supplements;Jun95 Supplement 5, Vol. 103, p25 

    Discusses the potential of cytochrome P450 enzymes in biodegradation technology. High catalytic rates and facile expression in microorganisms; Three-dimensional structures of bacterial cytochrome P450 enzymes; Advantages of random mutagenesis.

  • Cytochrome P450s Potential Catalysts for Asymmetric Olefin Epoxidations. Martinez, Carlos A.; Stewart, Jon D. // Current Organic Chemistry;Mar2000, Vol. 4 Issue 3, p263 

    Cytochrome P450 monooxygenases (P450s; EC 1.14.14.1) catalyze a variety of oxidations, although they are best known for hydroxylations and olefin epoxidations. Such enzymes also might be useful in asymmetric synthesis since different forms accept aromatic polycyclic hydro-carbons, prochiral and...

  • Cytochrome P450 Gene-directed Enzyme Prodrug Therapy (GDEPT) for Cancer. L. Chen; D.J. Waxman // Current Pharmaceutical Design;Jul2002, Vol. 8 Issue 15, p1405 

    Several commonly used cancer chemotherapeutic prodrugs, including cyclophosphamide and ifosfamide, are metabolized in the liver by a cytochrome P450 (CYP)-catalyzed prodrug activation reaction that is required for therapeutic activity. Preclinical studies have shown that the chemosensitivity of...

  • Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy. Njar, V.C.O. // Mini Reviews in Medicinal Chemistry;Jun2002, Vol. 2 Issue 3, p261 

    Retinoids play a crucial role in cellular differentiation and proliferation of epithelial tissue and their utility in oncology and dermatology is well documented. This mini review focuses on the role of all-trans-retinoic acid (ATRA or RA), the principal endogenous retinoid and its metabolism in...

  • Mechanism-Based Inactivators as Probes of Cytochrome P450 Structure and Function. Kent, Ute M.; Jushchyshyn, Monica I.; Hollenberg, Paul F. // Current Drug Metabolism;Sep2001, Vol. 2 Issue 3, p215 

    The cytochromes P450 superfamily of enzymes is a group of hemeproteins That catalyze the metabolism of an extensive series of compounds including drugs, chemical carcinogens, fatty acids, and steroids. They oxidize substrates ranging in size from ethylene to cyclosporin. Although significant...

  • Editorial. PRAKASH, CHANDRA // Current Drug Metabolism;Sep2009, Vol. 10 Issue 7, p659 

    The article discusses various reports published within the issue, including one on the ADME processes that govern the pharmacokinetics of biotech drugs, one on delineating human cytochrome P450 from structure, function and regulation of Substrate Specificity and Polymorphism, and one on the...

  • Dechlorination mechanisms of chlorinated olefins Van Dyke, R. A. // Environmental Health Perspectives;Dec1977, Vol. 21, p121 

    No abstract available.

  • Drug-Cytokine Interactions: Mechanisms and Clinical Implications. Reiss, W.G.; Piscitelli, S.C. // BioDrugs;1998, Vol. 9 Issue 5, p389 

    The potential for certain cytokines to alter cytochrome P450-mediated drug metabolism was first described over 20 years ago. Since that time, a number of in vitro studies in a variety of models have confirmed those observations and evaluated the possible mechanisms. Although the actual...

  • Effects of CYP3A Inhibition on the Metabolism of Cilostazol. Suri, A.; Forbes, W.P.; Bramer, S.L. // Clinical Pharmacokinetics;1999 Supplement, Vol. 37 Issue 6, p61 

    Objective: In vitro results suggest that cilostazol is metabolised by cytochrome P450 (CYP) isoforms 1A2, 2D6, 3A and 2C19. This study investigated the role of CYP3A inhibition on the metabolism of cilostazol. Design: The study was conducted as a single-centre, open-label, nonrandomised,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics